In the downstream purification of antibody drugs (such as monoclonal antibodies, bispecific antibodies, and Fc fusion proteins), the polishing step—especially the removal of aggregates, host cell proteins (HCPs), DNA, and viruses—is crucial for product quality. Conventional cation exchange chromatography (CEX) is widely used but often faces challenges such as narrow operational windows and restricted impurity removal efficiency when handling complex samples or pursuing greater process robustness.
To address these challenges, multimodal chromatography has emerged as a vital supplement, and even an alternative, to conventional cation exchange chromatography. By combining multiple interaction mechanisms (such as electrostatic forces, hydrophobic interactions, and hydrogen bonding), multimodal chromatography allows for more efficient impurity removal under broader operating conditions while maintaining high product recovery.
This article highlights the performance characteristics and application cases of BioLink MMC series cation multimodal resins in antibody purification
MaXtar® MMC (average particle size: 90 μm) and MaXtar® MMC HR (average particle size: 40 μm) resins incorporate functional groups with different properties: carboxyl, hydrogen bonding, and hydrophobic moieties. Compared to traditional single-mode chromatography resins, these multimodal ligands exhibit a combination of multiple interaction forces, enabling the selective removal of diverse impurities in a single step. This results in higher recovery and superior product quality, offering significant performance advantages:
High binding capacity saves time and reduces cost; HR's smaller particles offer higher resolution.
Broad operating window for pH and conductivity in production-scale processes.
Robust MaXtar® matrix withstands high pressures, making scale-up straightforward.
With excellent salt tolerance, MaXtar® MMC is ideal for capture steps in recombinant protein processes, reducing the need for buffer exchange.
High impurity clearance efficiency, especially for aggregates, in intermediate or polishing steps of antibody purification.
Column volume: 4.7 mL
Sample: Purified IgG1 (expressed in CHO cells)
Residence time: Sample loading duration: 5 min
Binding buffer: 50 mM HAc-NaAc, pH 5.5

Figure 1: MaXtar® MMC Antibody Binding Capacity
Summary:Under ionic-binding mode, average binding capacity: MaXtar® MMC: 50 mg/mL; MaXtar® MMC HR: 60 mg/mL

Figure 2: MaXtar® MMC Salt Tolerance Test
Summary: Under ionic-binding mode, when using 50 mM HAc–NaAc, pH 5.5 buffer and progressively increasing NaCl concentrations, IgG remained well bound up to 150 mM NaCl(17 mS/cm).

Figure 3: MaXtar® MMC Pressure-Flow Curve

Figure 4: MaXtar® MMC HR Pressure-Flow Curve
Summary: Both MaXtar® MMC and MaXtar® MMC HR show excellent mechanical performance. The finer-particle HR variant maintains performance suitable for commercial-scale applications while delivering higher resolution.
Test Conditions:
Resin: MaXtar® MMC HR
Sample: monoclonal antibody sample (15 mg/mL)
Buffer A: 50 mM NaAc-HAc, pH 5.5
Buffer B: 20 mM PB, 0.5 M NaCl, pH 7.0
Sample | SEC purity | NE-CE purity | ||||
HMW (%) | Monomer (%) | LMW (%) | HMW (%) | Monomer (%) | LMW (%) | |
Load | 6.43 | 79.58 | 13.99 | 5.55 | 75.58 | 18.87 |
Elution | 0.45 | 98.43 | 1.12 | 0.00 | 98.11 | 1.89 |
Table 1: MaXtar® MMC HR Process Data
Summary: After purification with MaXtar® MMC HR, aggregate content dropped from 6.43 % to 0.45 %, and fragments decreased from 13.99 % to 1.12 %. The results demonstrate that MaXtar® MMC HR provides a clear and effective removal of both aggregates and fragments.
Test Conditions:
· Resin: MaXtar® MMC HR, 4.7 mL column
· Load: Sample at 3 mS/cm, pH 5.5 (<20 mg/mL)
· Buffer A: 50 mM NaAc–HAc, pH 5.5
· Buffer B: 50 mM NaAc–HAc + 1 M NaCl, pH 5.5

Figure 5: Elution Profile of MaXtar® MMC HR
Figure 6: Acidic/basic Peak Detection Chromatogram of MaXtar® MMC HR
Sample | Yield (%) | Charge Variants | ||
Acidic Peak (%) | Main Peak (%) | Basic Peak (%) | ||
Load | / | 45 | 53 | 2 |
Elution | 78 | 33 | 66 | 1 |
Table 2: MaXtar® MMC HR Process Data
Summary: The results show that MaXtar® MMC HR effectively removes acidic charge variants. Acidic peak elute first, followed by basic peak.
MaXtar® MMC has an average particle size of 90 μm, while MaXtar® MMC HR is 40 μm. In addition to particle size differences, MMC HR features a lower ligand density than MMC, resulting in weaker binding strength. If overly strong binding is observed during process development, MMC HR is recommended.
For highly hydrophobic samples, if elution cannot be achieved effectively using standard salt or pH conditions with the MMC series, a combined salt/pH gradient is recommended.
When the sample contains high levels of product-related impurities such as aggregates, fragments, or charge variants, the higher resolution of MaXtar® MMC HR is recommended.
Process development should be guided by the specific properties of the sample and purification goals. Special attention should be paid to achieving a balance between product purity and recovery yield.
PREV
Link With Us Now!